Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2001 2
2002 1
2003 1
2004 2
2007 1
2008 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke.
Redman AR, Ryan GJ. Redman AR, et al. Expert Opin Pharmacother. 2004 Jan;5(1):117-23. doi: 10.1517/14656566.5.1.117. Expert Opin Pharmacother. 2004. PMID: 14680441 Review.
Chromium as adjunctive treatment for type 2 diabetes.
Ryan GJ, Wanko NS, Redman AR, Cook CB. Ryan GJ, et al. Among authors: redman ar. Ann Pharmacother. 2003 Jun;37(6):876-85. doi: 10.1345/aph.1C304. Ann Pharmacother. 2003. PMID: 12773078 Review.
Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
Redman AR, Allen LC. Redman AR, et al. Curr Atheroscler Rep. 2002 Jul;4(4):319-25. doi: 10.1007/s11883-002-0011-9. Curr Atheroscler Rep. 2002. PMID: 12052284 Review.
CYP2C9 genetic polymorphisms and warfarin.
Redman AR, Dickmann LJ, Kidd RS, Goldstein JA, Ritchie DM, Hon YY. Redman AR, et al. Clin Appl Thromb Hemost. 2004 Apr;10(2):149-54. doi: 10.1177/107602960401000205. Clin Appl Thromb Hemost. 2004. PMID: 15094935
Variant CYP2C9 alleles and warfarin concentrations in patients receiving low-dose versus average-dose warfarin therapy.
Redman AR, Zheng J, Shamsi SA, Huo J, Kelly EJ, Ho RJ, Ritchie DM, Hon YY. Redman AR, et al. Clin Appl Thromb Hemost. 2008 Jan;14(1):29-37. doi: 10.1177/1076029607304403. Epub 2007 Sep 25. Clin Appl Thromb Hemost. 2008. PMID: 17895500
Feedback